157 related articles for article (PubMed ID: 8565221)
1. Current status and performance goals for serum thyroglobulin assays.
Spencer CA; Takeuchi M; Kazarosyan M
Clin Chem; 1996 Jan; 42(1):164-73. PubMed ID: 8565221
[TBL] [Abstract][Full Text] [Related]
2. Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.
Spencer C; Petrovic I; Fatemi S; LoPresti J
J Clin Endocrinol Metab; 2014 Dec; 99(12):4589-99. PubMed ID: 25226290
[TBL] [Abstract][Full Text] [Related]
3. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
Crane MS; Strachan MW; Toft AD; Beckett GJ
Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas.
Spencer CA; Bergoglio LM; Kazarosyan M; Fatemi S; LoPresti JS
J Clin Endocrinol Metab; 2005 Oct; 90(10):5566-75. PubMed ID: 15985472
[TBL] [Abstract][Full Text] [Related]
5. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer.
Spencer C; Petrovic I; Fatemi S
J Clin Endocrinol Metab; 2011 May; 96(5):1283-91. PubMed ID: 21325460
[TBL] [Abstract][Full Text] [Related]
6. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.
Spencer CA; Wang CC
Endocrinol Metab Clin North Am; 1995 Dec; 24(4):841-63. PubMed ID: 8608781
[TBL] [Abstract][Full Text] [Related]
7. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
[TBL] [Abstract][Full Text] [Related]
8. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
[TBL] [Abstract][Full Text] [Related]
9. Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma.
Persoon AC; Links TP; Wilde J; Sluiter WJ; Wolffenbuttel BH; van den Ouweland JM
Clin Chem; 2006 Jun; 52(6):1196-9. PubMed ID: 16574765
[TBL] [Abstract][Full Text] [Related]
10. Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin.
Morgenthaler NG; Froehlich J; Rendl J; Willnich M; Alonso C; Bergmann A; Reiners C
Clin Chem; 2002 Jul; 48(7):1077-83. PubMed ID: 12089177
[TBL] [Abstract][Full Text] [Related]
11. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.
Spencer CA; Lopresti JS
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):223-33. PubMed ID: 18268520
[TBL] [Abstract][Full Text] [Related]
12. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
Spencer C; Fatemi S
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
[TBL] [Abstract][Full Text] [Related]
13. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
Spencer CA
J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
[TBL] [Abstract][Full Text] [Related]
14. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
16. Serum thyroglobulin in the monitoring of differentiated thyroid cancer.
Evans C; Tennant S; Perros P
Scand J Clin Lab Invest Suppl; 2016; 245():S119-23. PubMed ID: 27542000
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three immunoassay kits for serum thyroglobulin in patients with thyroid cancer.
Dai J; Dent W; Atkinson JW; Cox JG; Dembinski TC
Clin Biochem; 1996 Oct; 29(5):461-5. PubMed ID: 8884068
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of a new thyroglobulin immunoradiometric assay in the follow-up of differentiated thyroid carcinoma].
Sahlmann CO; Schreivogel I; Angerstein C; Siefker U; Lehmann K; Altenvoerde G; Hüfner M; Meller J
Nuklearmedizin; 2003; 42(2):71-7. PubMed ID: 12695789
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of three chemiluminescent methods with a radioimmunoassay for thyroglobulin measurement in the follow-up of differentiated thyroid cancer].
Sylla NM; Bombled C; Schlumberger M; Bidart JM
Dakar Med; 2007; 52(3):225-30. PubMed ID: 19097407
[TBL] [Abstract][Full Text] [Related]
20. Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital.
Wheeler SE; Liu L; Blair HC; Sivak R; Longo N; Tischler J; Mulvey K; Palmer OMP
BMC Res Notes; 2017 Dec; 10(1):725. PubMed ID: 29221487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]